BTG3 and hepatocellular carcinoma: In contrast, the overexpression of BTG3 also had a similar effect of miR-106b-5p inhibitor and resulted in decreased cell proliferation (Figure 4(a)), G1/S transition (Figure 4(d)), migratory and invasive ability in HCC-LM3 and MHCC-97H cells (Figures 4(b) and 4(c)).